鼻癌中的代谢重编程:机制和治疗机会
Qian Liu1, Ann M Bode2, Xue Chen3
1NHC Key Laboratory of Carcinogenesis and Hunan Key Laboratory of Oncotarget Gene, Hunan Cancer Hospital and The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, Hunan 410013, PR China; Key Laboratory of Carcinogenesis and Invasion, Chinese Ministry of Education, Cancer Research Institute, School of Basic Medicine, Central South University, Changsha, Hunan 410078, PR China.
在鼻癌 (NPC) 中的代谢重编程,由爱斯坦-巴尔病毒 (EBV) 和瘤微环境驱动,推动治疗抵抗. 针对这些代谢变化为NPC提供了新的治疗策略.
科学领域:
- 在瘤学瘤学.
- 代谢途径 代谢途径
- 癌症生物学 癌症生物学
背景情况:
- 鼻癌 (NPC) 经常表现出代谢重编程.
- 代谢变化对于NPC发育和治疗耐药性至关重要.
研究的目的:
- 审查NPC中代谢重编程的机制.
- 探索新陈代谢重编程在治疗耐药性的作用.
- 评估针对NPC中的代谢途径的当前和未来的治疗策略.
主要方法:
- 在NPC中对代谢重编程的文献综述.
- 分析包括糖解,核酸合成和脂质代谢在内的机制.
- 对爱斯坦-巴尔病毒 (EBV) 感染,缺氧和瘤微环境影响的评估.
主要成果:
- 代谢重编程,包括增强的糖解,核酸合成和脂质代谢,在NPC中很普遍.
- 这些代谢变化受到EBV,缺氧和瘤微环境的影响.
- 代谢重编程对NPC对标准疗法的耐药性有显著的贡献.
结论:
- 准代谢重编程为NPC提供了有前途的治疗策略.
- 了解抵抗机制是开发有效治疗方法的关键.
- 本综述提供了NPC治疗中代谢向的全面前景.
更多相关视频
06:11Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma
Published on: April 20, 2018
06:51Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
Published on: July 21, 2018
相关概念视频
Targeted Cancer Therapies
There are several types of targeted therapies against...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Methods of Nuclear Reprogramming
Abnormal Proliferation
Introduction to Nuclear Reprogramming
